NO20011173L - Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer - Google Patents

Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Info

Publication number
NO20011173L
NO20011173L NO20011173A NO20011173A NO20011173L NO 20011173 L NO20011173 L NO 20011173L NO 20011173 A NO20011173 A NO 20011173A NO 20011173 A NO20011173 A NO 20011173A NO 20011173 L NO20011173 L NO 20011173L
Authority
NO
Norway
Prior art keywords
fats
preparations
methods
intestinal absorption
increasing intestinal
Prior art date
Application number
NO20011173A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011173D0 (no
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of NO20011173D0 publication Critical patent/NO20011173D0/no
Publication of NO20011173L publication Critical patent/NO20011173L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20011173A 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer NO20011173L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (2)

Publication Number Publication Date
NO20011173D0 NO20011173D0 (no) 2001-03-07
NO20011173L true NO20011173L (no) 2001-05-08

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011173A NO20011173L (no) 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Country Status (13)

Country Link
US (1) US6426069B1 (https=)
EP (1) EP1119360B1 (https=)
JP (1) JP4700193B2 (https=)
CN (1) CN1321089A (https=)
AT (1) ATE347371T1 (https=)
AU (1) AU771901B2 (https=)
CA (1) CA2343116C (https=)
DE (1) DE69934325T2 (https=)
IL (2) IL141801A0 (https=)
NO (1) NO20011173L (https=)
NZ (1) NZ510536A (https=)
WO (1) WO2000013689A1 (https=)
ZA (1) ZA200102268B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161178A0 (en) * 2001-10-11 2004-08-31 Biomolecular Products Inc MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
DE60238663D1 (de) 2002-04-05 2011-02-03 Nestle Sa Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
JP2006518384A (ja) * 2003-01-31 2006-08-10 チルドレンズ・ホスピタル・ロス・アンジエルス 改善されたバイオアベイラビリティを有するフェンレチニドの経口組成物、およびその使用方法
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
US10463229B2 (en) * 2010-10-22 2019-11-05 Fukuoka University Endoscopic observation method and composition for improving diagnostic performance involving applying useful white opaque substance to diagnosis of gastric epithelial tumors (adenoma or gastric cancer)
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) * 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
WO2025148196A1 (zh) * 2024-01-12 2025-07-17 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
ES2071332T3 (es) 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
JPH11506780A (ja) * 1995-06-06 1999-06-15 バイオモレキュラー プロダクツ,インク. 薬またはカロリー送達用の混合脂質−重炭酸塩コロイド粒子
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
WO1998010776A1 (en) * 1996-09-11 1998-03-19 Shanahan Prendergast Elizabeth Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
DE69934325D1 (de) 2007-01-18
US6426069B1 (en) 2002-07-30
WO2000013689A1 (en) 2000-03-16
ZA200102268B (en) 2001-09-19
EP1119360A4 (en) 2003-06-04
CN1321089A (zh) 2001-11-07
IL141801A (en) 2009-02-11
CA2343116C (en) 2008-11-18
NO20011173D0 (no) 2001-03-07
JP4700193B2 (ja) 2011-06-15
ATE347371T1 (de) 2006-12-15
JP2002524417A (ja) 2002-08-06
NZ510536A (en) 2003-07-25
EP1119360B1 (en) 2006-12-06
CA2343116A1 (en) 2000-03-16
EP1119360A1 (en) 2001-08-01
AU771901B2 (en) 2004-04-08
AU5705299A (en) 2000-03-27
IL141801A0 (en) 2002-03-10
DE69934325T2 (de) 2007-07-05

Similar Documents

Publication Publication Date Title
NO973489D0 (no) Stabilisert gassemulsjon inneholdende fosfolipid til kontrastforbedring ved ultralydundersökelser
NO20011173L (no) Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer
ZA966798B (en) Methods of reducing or maintaining reduced levels of blood lipids using OB protein compositions.
IS5566A (is) Afurðir úr karótínsskyldum fituefnahlutum sæbjúgna og aðferðir við notkun þeirra
EP1435946B8 (en) Linked biaryl compounds
NO971643D0 (no) Eter liptid-liposomer og terapeutisk anvendelse derav
ATE169923T1 (de) Neue kationische phospholipide zur transfektion
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
DE60136490D1 (de) Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
DK1303632T3 (da) Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf
NO20024722D0 (no) Stivelses-subtyper og lipid metabolisme
BRPI0309421B8 (pt) método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
DK0882136T3 (da) Fremgangsmåder til fremstilling af lysophosphatidylcholin
DK1035859T3 (da) Anvendelse af phospholipidkomplekser fra ekstrakter af Vitis vinifera som anti-atherosklerotiske midler
EP0735102A3 (en) Process for making one-component RTV silicone compositions
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
IL139144A0 (en) Mycobacterial inhibitors
FR2753200B1 (fr) Procede d'extraction de lipides provenant de la lecithine de soja, extrait lipidique obtenu et compositions dermato-cosmetiques le contenant
NO992107D0 (no) FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet
WO2000027429A3 (en) Vaccine against papillomatous digital dermatitis (pdd)
DE69918826D1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
UA40878A (uk) Спосіб правосторонньої геміколектомії
FR2752729B1 (fr) Appareil de relaxation sexuelle automatisee
GB0119873D0 (en) Compositions for aiding the removal of lipid or fat and control of cholesterol comprising chitosan and method of using same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application